Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting.

Adrenal Gland Neoplasms / pathology Carcinoma / pathology Humans Paraganglioma / pathology Pathology, Clinical / standards Pheochromocytoma / pathology Research Design / standards
Checklist Data set ICCR Paraganglioma Pheochromocytoma Structured report Synoptic reporting

Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
04 2021
Historique:
received: 24 04 2020
accepted: 28 04 2020
pubmed: 15 5 2020
medline: 7 9 2021
entrez: 15 5 2020
Statut: ppublish

Résumé

The International Collaboration on Cancer Reporting (ICCR) is a not-for-profit to develop evidence-based, internationally agreed-upon standardized data sets for each anatomic site, to be used throughout the world. Providing global standardization of pathology tumor classification, staging, and other reporting elements will lead to improved patient management and enhanced epidemiological research. Pheochromocytoma and paraganglioma are uncommon and are frequently overlooked in registry data sets. Malignant criteria have previously been defined only when there was metastatic disease. With recent recognition of a significant inheritance association and the development of risk stratification tools, this data set was created in order to obtain more meaningful outcomes and management data, using similar criteria across the global pathology community. Issues related to key core and non-core elements, especially clinical hormonal status, familial history, tumor focality, proliferative fraction, adverse or risk stratification features, and ancillary techniques, are discussed in the context of daily application to these types of specimens. The ICCR data set, developed by an international panel of endocrine organ specialists, establishes a pathology-standardized reporting guide for pheochromocytoma and paraganglioma.

Sections du résumé

BACKGROUND AND OBJECTIVES
The International Collaboration on Cancer Reporting (ICCR) is a not-for-profit to develop evidence-based, internationally agreed-upon standardized data sets for each anatomic site, to be used throughout the world. Providing global standardization of pathology tumor classification, staging, and other reporting elements will lead to improved patient management and enhanced epidemiological research.
METHODS
Pheochromocytoma and paraganglioma are uncommon and are frequently overlooked in registry data sets. Malignant criteria have previously been defined only when there was metastatic disease.
RESULTS
With recent recognition of a significant inheritance association and the development of risk stratification tools, this data set was created in order to obtain more meaningful outcomes and management data, using similar criteria across the global pathology community. Issues related to key core and non-core elements, especially clinical hormonal status, familial history, tumor focality, proliferative fraction, adverse or risk stratification features, and ancillary techniques, are discussed in the context of daily application to these types of specimens.
CONCLUSIONS
The ICCR data set, developed by an international panel of endocrine organ specialists, establishes a pathology-standardized reporting guide for pheochromocytoma and paraganglioma.

Identifiants

DOI: 10.1016/j.humpath.2020.04.012 PMID: 32407815 PMC: PMC7655677
pubmed: 32407815
pii: S0046-8177(20)30084-8
doi: 10.1016/j.humpath.2020.04.012
pmc: PMC7655677
mid: NIHMS1614048
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

83-97

Subventions

Organisme : NCI NIH HHS
ID : P01 CA240239
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Acta Otorrinolaringol Esp. 2018 May - Jun;69(3):156-164
pubmed: 29033121
Neoplasia. 2014 Oct 23;16(10):868-73
pubmed: 25379023
J Clin Med. 2018 Aug 27;7(9):
pubmed: 30150569
Virchows Arch. 2018 Jun;472(6):939-947
pubmed: 29392400
Am J Surg Pathol. 2014 Jan;38(1):13-22
pubmed: 24145643
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
Cancer Cytopathol. 2016 Dec;124(12):871-884
pubmed: 27529763
Eur Urol. 2011 Jul;60(1):118-24
pubmed: 21507561
Arch Pathol Lab Med. 2008 Aug;132(8):1272-84
pubmed: 18684026
Yonsei Med J. 2016 Nov;57(6):1324-8
pubmed: 27593858
Hum Pathol. 2018 Jan;71:47-54
pubmed: 29079178
Endocr Relat Cancer. 2015 Aug;22(4):T123-33
pubmed: 26136457
Nat Rev Endocrinol. 2017 Apr;13(4):233-247
pubmed: 27857127
J Oncol Pract. 2013 Sep;9(5):e255-61
pubmed: 23943888
Surgery. 2008 Jun;143(6):759-68
pubmed: 18549892
Surgery. 2001 Dec;130(6):1072-7
pubmed: 11742341
Arch Pathol Lab Med. 2014 Feb;138(2):182-8
pubmed: 24476517
Endocr Pathol. 2018 Dec;29(4):302-309
pubmed: 30155766
Endocr Pathol. 2020 Jun;31(2):95-100
pubmed: 32303954
Am J Surg Pathol. 2009 Apr;33(4):599-608
pubmed: 19145205
CMAJ. 1997 Oct 1;157(7):923-5
pubmed: 9327801
Hum Pathol. 2010 Jun;41(6):805-14
pubmed: 20236688
Head Neck Pathol. 2020 Sep;14(3):666-688
pubmed: 31741151
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Am J Pathol. 1998 Jul;153(1):223-31
pubmed: 9665483
Clin Biochem Rev. 2017 Apr;38(2):69-100
pubmed: 29332973
Mod Pathol. 2015 Jun;28(6):807-21
pubmed: 25720320
Mod Pathol. 2007 Jan;20(1):44-53
pubmed: 17170742
Radiology. 1986 Jun;159(3):733-5
pubmed: 3517958
Semin Diagn Pathol. 2013 Aug;30(3):207-23
pubmed: 24144290
Diagn Cytopathol. 2017 Jun;45(6):565-568
pubmed: 28261927
Am J Surg Pathol. 2002 May;26(5):551-66
pubmed: 11979086
Histopathology. 2018 Jan;72(1):97-105
pubmed: 29239044
Oncotarget. 2017 May 26;8(37):61393-61403
pubmed: 28977872
Lancet Oncol. 2009 Aug;10(8):764-71
pubmed: 19576851
Am J Surg Pathol. 1987 Jun;11(6):480-6
pubmed: 3592062
Ann Surg. 2014 Jul;260(1):158-62
pubmed: 24169168
Cancers (Basel). 2019 Feb 15;11(2):
pubmed: 30769931
BMC Med Res Methodol. 2009 Jun 11;9:34
pubmed: 19519887
J Clin Med. 2018 Sep 13;7(9):
pubmed: 30217041
Hum Mol Genet. 2014 May 1;23(9):2440-6
pubmed: 24334767
Hepatobiliary Pancreat Dis Int. 2016 Dec;15(6):572-578
pubmed: 27919845
Am J Pathol. 1976 Apr;83(1):177-96
pubmed: 1275056
Surgery. 2007 Oct;142(4):497-502; discussion 502-4
pubmed: 17950341
Ann Diagn Pathol. 2013 Dec;17(6):536-9
pubmed: 23806202
Endocr Relat Cancer. 2014 May 06;21(3):405-14
pubmed: 24521857
Histol Histopathol. 1993 Jul;8(3):429-36
pubmed: 8358154
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
Anticancer Res. 2017 Feb;37(2):805-812
pubmed: 28179334
J Dig Dis. 2017 Jan;18(1):2-12
pubmed: 28009094
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
J Clin Pathol. 2016 Nov;69(11):956-961
pubmed: 27387986
Virchows Arch A Pathol Anat Histopathol. 1992;421(1):25-32
pubmed: 1353277
BMC Cancer. 2018 Sep 29;18(1):935
pubmed: 30268112
Curr Opin Endocrinol Diabetes Obes. 2017 Jun;24(3):174-183
pubmed: 28234804
Genet Med. 2019 Mar;21(3):705-717
pubmed: 30050099
Endoscopy. 2014;46 Suppl 1 UCTN:E447-8
pubmed: 25314187
APMIS. 2014 Nov;122(11):1130-5
pubmed: 24735130
J Med Genet. 2015 Oct;52(10):647-56
pubmed: 26269449
Endocr Relat Cancer. 2015 Aug;22(4):T91-103
pubmed: 26273102
Virchows Arch. 2016 Jan;468(1):51-9
pubmed: 26316184
Am J Surg Pathol. 2018 May;42(5):665-671
pubmed: 29438167
Eur J Cancer. 2012 Jul;48(11):1739-49
pubmed: 22036874
J Hepatobiliary Pancreat Surg. 2007;14(3):289-96
pubmed: 17520205
Endocr Pathol. 2017 Dec;28(4):302-307
pubmed: 27838885
Neuroendocrinology. 2015;101(4):289-95
pubmed: 25677368
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):92-102
pubmed: 17237836
Ann Diagn Pathol. 2004 Aug;8(4):237-41
pubmed: 15290677

Auteurs

Lester D R Thompson (LDR)

Southern California Permanente Medical Group, Woodland Hills Medical Center, Woodland Hills, CA, USA. Electronic address: lester.d.thompson@kp.org.

Anthony J Gill (AJ)

University of Sydney, Sydney, New South Wales, Australia; Cancer Diagnosis and Pathology Group Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia. Electronic address: affgill@med.usyd.edu.au.

Sylvia L Asa (SL)

Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA; University Health Network, Toronto, Canada. Electronic address: PathLady01@gmail.com.

Roderick J Clifton-Bligh (RJ)

University of Sydney, Sydney, New South Wales, Australia; Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia. Electronic address: jclifton@med.usyd.edu.au.

Ronald R de Krijger (RR)

Department of Pathology, University Medical Centre and Princess Maxima Centre, Utrecht, the Netherlands. Electronic address: r.r.dekrijger@umcutrecht.nl.

Noriko Kimura (N)

Department of Diagnostic Pathology, Department of Clinical Research, Pathology Division, National Hospital Organization Hakodate Hospital, Japan. Electronic address: kimura.noriko.sf@mail.hosp.go.jp.

Paul Komminoth (P)

University of Zürich, Institute of Pathology, City Hospital Triemli, Zürich, Switzerland. Electronic address: paul.komminoth@triemli.zuerich.ch.

Ernest E Lack (EE)

Department of Endocrine Pathology, The Joint Pathology Center, Silver Spring, MD, USA. Electronic address: ernest.e.lack.ctr@mail.mil.

Jacques W M Lenders (JWM)

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Medicine III, University Hospital Carl Gustav Carus and Medical Faculty, Technical University Dresden, Dresden, Germany. Electronic address: Jacques.Lenders@radboudumc.nl.

Ricardo V Lloyd (RV)

Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Wisconsin, USA. Electronic address: rvlloyd@wisc.edu.

Thomas G Papathomas (TG)

Institute of Metabolism and Systems Research, University of Birmingham, United Kingdom. Electronic address: thomaspapathomas@nhs.net.

Peter M Sadow (PM)

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA. Electronic address: psadow@partners.org.

Arthur S Tischler (AS)

Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, USA. Electronic address: atischler@tuftsmedicalcenter.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Carcinomes › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Paragangliome › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Professions de santé › Médecine › Anatomopathologie › Anatomopathologie clinique › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Paragangliome › Phéochromocytome › Data set for the reporting of pheochromocytoma...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Plan de recherche › Data set for the reporting of pheochromocytoma...